Caitlin E Martin1,2, Tawany Almeida3, Bhushan Thakkar1, Tiffany Kimbrough4. 1. Department of Obstetrics and Gynecology, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA. 2. Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, USA. 3. School of Medicine, Virginia Commonwealth University, Richmond, VA, USA. 4. Department of Pediatrics, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA.
Abstract
Background: Postpartum is a highly vulnerable time for women with opioid use disorder (OUD). Our primary objective was to identify patient and provider reported aspects of the pregnancy to postpartum transition that impact recovery progress for postpartum women receiving medication for opioid use disorder (MOUD). Methods: This qualitative study consisted of semi-structured interviews with postpartum women in OUD treatment (n = 12) and providers (n = 9) at an outpatient addiction clinic. Interviews were transcribed and analyzed using an editing style approach to report themes and quotes. Results: Patients and providers identified different themes that both promote and challenge recovery during the postpartum transition. These comprised of clinical factors, including MOUD, neonatal opioid withdrawal syndrome (NOWS) and pain associated with labor and delivery as well as psychosocial factors, such as role of a support system, mental health aspects of anxiety and depression causing mood changes, stigma and mistrust among healthcare providers and child welfare. Conclusions: Patients receiving MOUD and their providers identified multiple aspects unique to the postpartum transition that substantially strengthen and/or oppose OUD recovery. These aspects impacting recovery include factors specific to the receipt of MOUD treatment and those not specific to MOUD, yet tied to the postpartum state. Overall, these findings provide insight into areas for future research focused on identifying opportunities to promote recovery-oriented care for families affected by OUD.
Background: Postpartum is a highly vulnerable time for women with opioid use disorder (OUD). Our primary objective was to identify patient and provider reported aspects of the pregnancy to postpartum transition that impact recovery progress for postpartum women receiving medication for opioid use disorder (MOUD). Methods: This qualitative study consisted of semi-structured interviews with postpartum women in OUD treatment (n = 12) and providers (n = 9) at an outpatient addiction clinic. Interviews were transcribed and analyzed using an editing style approach to report themes and quotes. Results: Patients and providers identified different themes that both promote and challenge recovery during the postpartum transition. These comprised of clinical factors, including MOUD, neonatal opioid withdrawal syndrome (NOWS) and pain associated with labor and delivery as well as psychosocial factors, such as role of a support system, mental health aspects of anxiety and depression causing mood changes, stigma and mistrust among healthcare providers and child welfare. Conclusions: Patients receiving MOUD and their providers identified multiple aspects unique to the postpartum transition that substantially strengthen and/or oppose OUD recovery. These aspects impacting recovery include factors specific to the receipt of MOUD treatment and those not specific to MOUD, yet tied to the postpartum state. Overall, these findings provide insight into areas for future research focused on identifying opportunities to promote recovery-oriented care for families affected by OUD.
Entities:
Keywords:
Opioid use disorder; neonatal opioid withdrawal syndrome; postpartum; recovery; women
Authors: Marcela C Smid; Nicole M Stone; Laurie Baksh; Michelle P Debbink; Brett D Einerson; Michael W Varner; Adam J Gordon; Erin A S Clark Journal: Obstet Gynecol Date: 2019-06 Impact factor: 7.661
Authors: Timothy Nielsen; Dana Bernson; Mishka Terplan; Sarah E Wakeman; Amy M Yule; Pooja K Mehta; Monica Bharel; Hafsatou Diop; Elsie M Taveras; Timothy E Wilens; Davida M Schiff Journal: Addiction Date: 2019-11-13 Impact factor: 6.526
Authors: Jennifer D Ellis; Molly Cairncross; Cara A Struble; Meagan M Carr; David M Ledgerwood; Leslie H Lundahl Journal: J Addict Med Date: 2019 Mar/Apr Impact factor: 3.702
Authors: Magdalena Romanowicz; Jennifer L Vande Voort; Julia Shekunov; Tyler S Oesterle; Nuria J Thusius; Teresa A Rummans; Paul E Croarkin; Victor M Karpyak; Brian A Lynch; Kathryn M Schak Journal: Child Adolesc Psychiatry Ment Health Date: 2019-01-12 Impact factor: 3.033